Adaptive Design Quanticate's collaboration with PhaseVtrials to develop software for adaptive clinical trial design signals a strategic move into ML-enabled trials. This creates sales opportunities to offer end-to-end data services for adaptive designs, including data management, biostatistics, SAS programming, and centralized statistical monitoring.

Safety PV Strength Quanticate's QVigilance pharmacovigilance platform and dedicated PV services underpin post-marketing safety and risk management capabilities. This positions the company to upsell PV and safety data management, signal detection, and regulatory-compliant reporting to sponsors across trials and post-approval programs.

Real World Evidence Recognition as a finalist for Excellence in Use of Real-World Evidence demonstrates strength in RWE analytics. This can be leveraged to offer RWE studies, observational data analyses, and regulatory-support services to sponsors pursuing evidence generation beyond traditional trial data.

Flexible FSP With a mid-size profile and a services portfolio spanning clinical data management, biostatistics, SAS programming and data quality oversight, Quanticate is well positioned to serve mid-market pharma and biotech with flexible functional service provision. Target this segment as a preferred outsourcing partner capable of scaling with sponsor needs.

Global Partnerships Strategic partnerships with Cancer Research UK, KPS Life, and a PhaseV collaboration indicate a growing global footprint and cross-border capabilities. Leverage these relationships to pursue multinational trials, co-sell opportunities, and expanded access to diverse data sources.